| Cape Fear Valley Hospice And Palliative Care 3400 Walsh Parkway Suite 100, Fayetteville, NC, 28311 | |
| (910) 609-6710 |
News Archive
Lung cancer is the number one cause of cancer-related deaths in the United States, with squamous cell lung cancer (SCC) being one of the common types.
Phytoceuticals Ltd. will present promising clinical and scientific data on 1 PRIMARY WOUND DRESSING at the 2011 EWMA Conference on May 26, the largest European wound management conference.
Acetylon Pharmaceuticals, Inc., the leader in the development of selective histone deacetylase inhibitors for enhanced therapeutic outcomes, today announced that positive interim clinical data from the two proof-of-concept clinical trials with selective HDAC6 inhibitor, ricolinostat (ACY-1215), were presented at the 55th Annual Meeting of the American Society of Hematology in New Orleans, LA.
A higher intake of vitamin C is crucial for metabolic syndrome patients trying to halt a potentially deadly cycle of antioxidant disruption and health-related problems, an Oregon State University researcher says.
› Verified 9 days ago
| Name | Cape Fear Valley Hospice And Palliative Care |
|---|---|
| Location | 3400 Walsh Parkway Suite 100, Fayetteville, North Carolina |
| Hospice ID | 341562 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 250 |
News Archive
Lung cancer is the number one cause of cancer-related deaths in the United States, with squamous cell lung cancer (SCC) being one of the common types.
Phytoceuticals Ltd. will present promising clinical and scientific data on 1 PRIMARY WOUND DRESSING at the 2011 EWMA Conference on May 26, the largest European wound management conference.
Acetylon Pharmaceuticals, Inc., the leader in the development of selective histone deacetylase inhibitors for enhanced therapeutic outcomes, today announced that positive interim clinical data from the two proof-of-concept clinical trials with selective HDAC6 inhibitor, ricolinostat (ACY-1215), were presented at the 55th Annual Meeting of the American Society of Hematology in New Orleans, LA.
A higher intake of vitamin C is crucial for metabolic syndrome patients trying to halt a potentially deadly cycle of antioxidant disruption and health-related problems, an Oregon State University researcher says.
› Verified 9 days ago
| NPI Number | 1033369616 |
| Organization Name | Cape Fear Valley Homecare And Hospice, Llc |
| Address | 1830 Owen Dr Fayetteville, North Carolina, 28304 |
| Phone Number | (910)609-6710 |
News Archive
Lung cancer is the number one cause of cancer-related deaths in the United States, with squamous cell lung cancer (SCC) being one of the common types.
Phytoceuticals Ltd. will present promising clinical and scientific data on 1 PRIMARY WOUND DRESSING at the 2011 EWMA Conference on May 26, the largest European wound management conference.
Acetylon Pharmaceuticals, Inc., the leader in the development of selective histone deacetylase inhibitors for enhanced therapeutic outcomes, today announced that positive interim clinical data from the two proof-of-concept clinical trials with selective HDAC6 inhibitor, ricolinostat (ACY-1215), were presented at the 55th Annual Meeting of the American Society of Hematology in New Orleans, LA.
A higher intake of vitamin C is crucial for metabolic syndrome patients trying to halt a potentially deadly cycle of antioxidant disruption and health-related problems, an Oregon State University researcher says.
› Verified 9 days ago
| NPI Number | 1255404059 |
| Organization Name | Liberty Healthcare Group, Llc |
| Address | 1830 Owen Dr Fayetteville, North Carolina, 28304 |
| Phone Number | (910)864-8411 |
News Archive
Lung cancer is the number one cause of cancer-related deaths in the United States, with squamous cell lung cancer (SCC) being one of the common types.
Phytoceuticals Ltd. will present promising clinical and scientific data on 1 PRIMARY WOUND DRESSING at the 2011 EWMA Conference on May 26, the largest European wound management conference.
Acetylon Pharmaceuticals, Inc., the leader in the development of selective histone deacetylase inhibitors for enhanced therapeutic outcomes, today announced that positive interim clinical data from the two proof-of-concept clinical trials with selective HDAC6 inhibitor, ricolinostat (ACY-1215), were presented at the 55th Annual Meeting of the American Society of Hematology in New Orleans, LA.
A higher intake of vitamin C is crucial for metabolic syndrome patients trying to halt a potentially deadly cycle of antioxidant disruption and health-related problems, an Oregon State University researcher says.
› Verified 9 days ago
| NPI Number | 1467643148 |
| Organization Name | Healthkeeperz, Inc. |
| Address | 1830 Owen Dr Fayetteville, North Carolina, 28304 |
| Phone Number | (910)522-0001 |
News Archive
Lung cancer is the number one cause of cancer-related deaths in the United States, with squamous cell lung cancer (SCC) being one of the common types.
Phytoceuticals Ltd. will present promising clinical and scientific data on 1 PRIMARY WOUND DRESSING at the 2011 EWMA Conference on May 26, the largest European wound management conference.
Acetylon Pharmaceuticals, Inc., the leader in the development of selective histone deacetylase inhibitors for enhanced therapeutic outcomes, today announced that positive interim clinical data from the two proof-of-concept clinical trials with selective HDAC6 inhibitor, ricolinostat (ACY-1215), were presented at the 55th Annual Meeting of the American Society of Hematology in New Orleans, LA.
A higher intake of vitamin C is crucial for metabolic syndrome patients trying to halt a potentially deadly cycle of antioxidant disruption and health-related problems, an Oregon State University researcher says.
› Verified 9 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.2 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 99.2 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 96.9 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 98.8 | 97.3 |
| Patients who got timely treatment for shortness of breath | 95.6 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 99.3 | 93.3 |
News Archive
Lung cancer is the number one cause of cancer-related deaths in the United States, with squamous cell lung cancer (SCC) being one of the common types.
Phytoceuticals Ltd. will present promising clinical and scientific data on 1 PRIMARY WOUND DRESSING at the 2011 EWMA Conference on May 26, the largest European wound management conference.
Acetylon Pharmaceuticals, Inc., the leader in the development of selective histone deacetylase inhibitors for enhanced therapeutic outcomes, today announced that positive interim clinical data from the two proof-of-concept clinical trials with selective HDAC6 inhibitor, ricolinostat (ACY-1215), were presented at the 55th Annual Meeting of the American Society of Hematology in New Orleans, LA.
A higher intake of vitamin C is crucial for metabolic syndrome patients trying to halt a potentially deadly cycle of antioxidant disruption and health-related problems, an Oregon State University researcher says.
› Verified 9 days ago
| Home Health Aides | 4 |
| Counselors | 1 |
| Homemakers | 4 |
| Licensed Practical or Vocational Nurses | 1 |
| Medical Social Workers | 1 |
| Physicians | 2 |
| Registered Nurses | 7 |
| Other Personnel | 4.5 |
| Total Employees | 24.5 |
|---|
News Archive
Lung cancer is the number one cause of cancer-related deaths in the United States, with squamous cell lung cancer (SCC) being one of the common types.
Phytoceuticals Ltd. will present promising clinical and scientific data on 1 PRIMARY WOUND DRESSING at the 2011 EWMA Conference on May 26, the largest European wound management conference.
Acetylon Pharmaceuticals, Inc., the leader in the development of selective histone deacetylase inhibitors for enhanced therapeutic outcomes, today announced that positive interim clinical data from the two proof-of-concept clinical trials with selective HDAC6 inhibitor, ricolinostat (ACY-1215), were presented at the 55th Annual Meeting of the American Society of Hematology in New Orleans, LA.
A higher intake of vitamin C is crucial for metabolic syndrome patients trying to halt a potentially deadly cycle of antioxidant disruption and health-related problems, an Oregon State University researcher says.
› Verified 9 days ago
| Others | 24.5 |
| Total Volunteers | 24.5 |
|---|
News Archive
Lung cancer is the number one cause of cancer-related deaths in the United States, with squamous cell lung cancer (SCC) being one of the common types.
Phytoceuticals Ltd. will present promising clinical and scientific data on 1 PRIMARY WOUND DRESSING at the 2011 EWMA Conference on May 26, the largest European wound management conference.
Acetylon Pharmaceuticals, Inc., the leader in the development of selective histone deacetylase inhibitors for enhanced therapeutic outcomes, today announced that positive interim clinical data from the two proof-of-concept clinical trials with selective HDAC6 inhibitor, ricolinostat (ACY-1215), were presented at the 55th Annual Meeting of the American Society of Hematology in New Orleans, LA.
A higher intake of vitamin C is crucial for metabolic syndrome patients trying to halt a potentially deadly cycle of antioxidant disruption and health-related problems, an Oregon State University researcher says.
› Verified 9 days ago
| Healthkeeperz, Inc Location: 4155 Ferncreek Drive, Suite 201, Fayetteville, North Carolina, 28314 Phone: (910) 609-6710 |
| Cape Fear Valley Hospice And Palliative Care Location: 3400 Walsh Parkway Suite 100, Fayetteville, North Carolina, 28311 Phone: (910) 609-6710 |
| Community Home Care & Hospice Location: 2800 Breezewood Avenue, Suite 100, Fayetteville, North Carolina, 28303 Phone: (910) 609-6710 |